BLTE vs. ^NDX

Last updated Jun 24, 2026

BLTE (Belite Bio Inc ADR) is a stock, while ^NDX (NASDAQ 100 Index) is an index. Over the past 3 years, BLTE returned 135.00%/yr vs 25.37%/yr for ^NDX. At a 0.13 correlation, their price movements are largely independent.

Performance

BLTE vs. ^NDX - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Belite Bio Inc ADR (BLTE) and NASDAQ 100 Index (^NDX). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

In the year-to-date period, BLTE achieves a -9.30% return, which is significantly lower than ^NDX's 16.23% return.

BLTE

• 1D: -1.35%
• 1M: 5.67%
• YTD: -9.30%
• 6M: -6.09%
• 1Y: 135.92%
• 3Y*: 135.00%
• 5Y*: —
• 10Y*: —

^NDX

• 1D: -3.29%
• 1M: -0.46%
• YTD: 16.23%
• 6M: 14.69%
• 1Y: 34.27%
• 3Y*: 25.37%
• 5Y*: 15.36%
• 10Y*: 21.21%

*Multi-year figures are annualized to reflect compound growth (CAGR)

BLTE vs. ^NDX - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022
BLTE Belite Bio Inc ADR	-9.30%	153.50%	37.92%	51.77%	141.16%
^NDX NASDAQ 100 Index	16.23%	20.17%	24.88%	53.81%	-18.70%

Correlation

The correlation between BLTE and ^NDX is 0.20, which is low. Their price movements are largely independent, making them effective diversification partners.

	Correlation
Correlation (1Y) Calculated over the trailing 1-year period	0.20
Correlation (3Y) Calculated over the trailing 3-year period	0.21
Correlation (All Time) Calculated using the full available price history since Apr 29, 2022	0.13

Return for Risk

BLTE vs. ^NDX — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

BLTE

BLTE Risk / Return Rank: 91
BLTE Sharpe Ratio Rank: 94
BLTE Sortino Ratio Rank: 91
BLTE Omega Ratio Rank: 88
BLTE Calmar Ratio Rank: 91
BLTE Martin Ratio Rank: 91

^NDX

^NDX Risk / Return Rank: 66
^NDX Sharpe Ratio Rank: 63
^NDX Sortino Ratio Rank: 61
^NDX Omega Ratio Rank: 65
^NDX Calmar Ratio Rank: 72
^NDX Martin Ratio Rank: 71

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

BLTE vs. ^NDX - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Belite Bio Inc ADR (BLTE) and NASDAQ 100 Index (^NDX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.

	BLTE	^NDX	Difference
Sharpe ratio: Return per unit of total volatility	2.61	1.91	+0.70
Sortino ratio: Return per unit of downside risk	3.21	2.52	+0.69
Omega ratio: Gain probability vs. loss probability	1.39	1.34	+0.05
Calmar ratio: Return relative to maximum drawdown	4.70	2.84	+1.86
Martin ratio: Return relative to average drawdown	11.95	10.49	+1.46

BLTE vs. ^NDX - Sharpe Ratio Comparison

The current BLTE Sharpe Ratio is 2.61, which is higher than the ^NDX Sharpe Ratio of 1.91. The chart below compares the historical Sharpe Ratios of BLTE and ^NDX, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.

Drawdowns

BLTE vs. ^NDX - Drawdown Comparison

The maximum BLTE drawdown since its inception was -74.59%, smaller than the maximum ^NDX drawdown of -82.90%. Use the drawdown chart below to compare losses from any high point for BLTE and ^NDX.

Drawdown Indicators

	BLTE	^NDX	Difference
Max Drawdown Largest peak-to-trough decline	-74.59%	-82.90%	+8.31%
Max Drawdown (1Y) Largest decline over 1 year	-29.10%	-12.12%	-16.98%
Max Drawdown (3Y) Largest decline over 3 years	-36.60%	-22.93%	-13.67%
Max Drawdown (5Y) Largest decline over 5 years	—	-35.56%	—
Max Drawdown (10Y) Largest decline over 10 years	—	-35.56%	—
Current Drawdown Current decline from peak	-23.76%	-4.28%	-19.48%
Average Drawdown Average peak-to-trough decline	-19.77%	-24.60%	+4.83%
Ulcer Index Depth and duration of drawdowns from previous peaks	11.43%	3.28%	+8.15%

Volatility

BLTE vs. ^NDX - Volatility Comparison

Belite Bio Inc ADR (BLTE) has a higher volatility of 17.12% compared to NASDAQ 100 Index (^NDX) at 9.08%. This indicates that BLTE's price experiences larger fluctuations and is considered to be riskier than ^NDX based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	BLTE	^NDX	Difference
Volatility (1M) Calculated over the trailing 1-month period	17.12%	9.08%	+8.04%
Volatility (6M) Calculated over the trailing 6-month period	32.84%	14.56%	+18.28%
Volatility (1Y) Calculated over the trailing 1-year period	52.30%	18.03%	+34.27%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	72.29%	22.89%	+49.40%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	72.29%	22.65%	+49.64%

Frequently Asked Questions

Can I hold both BLTE and ^NDX in my portfolio?

BLTE and ^NDX have a correlation of 0.20, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

Which is riskier, BLTE or ^NDX?

BLTE has higher volatility (17.12%) compared to ^NDX (9.08%). In terms of maximum drawdown, BLTE dropped -74.59% vs ^NDX's -82.90%.

Which has better risk-adjusted returns?

BLTE currently has the higher Sharpe Ratio (2.61 vs 1.91), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.